Skip to main content
. 2020 Sep 14;15:248. doi: 10.1186/s13023-020-01530-5

Table 3.

FM score at baseline(W0) and W24

ID W-24 W0 W24 W24-W0 W0-W-24
1 24.0 44.0 42.0 −2.0 20.0
2 63.0 72.0 61.0 −11.0 9.0
3 55.0 75.0 66.0 −9.0 20.0
4 8.0 12.0 9.0 −3.0 4.0
5 40.0 50.0 44.0 −6.0 10.0
6 90.0 102.0 94.0 −8.0 12.0
7 51.0 71.0 75.0 4.0 20.0
8 18.0 18.0 16.0 −2.0 0.0
9 15.0 31.0 35.0 4.0 16.0
10 65.0 60.0 61.0 1.0 −5.0
11 6.0 24.0 15.0 −9.0 18.0
12 60.0 70.0 76.5 6.5 10.0
13 46.0 49.0 56.0 7.0 3.0
14 36.0 51.0 74.0 23.0 15.0
15 23.0 49.0 67.0 18.0 26.0
M ± SD 40.0 ± 24.3 51.9 ± 24.3 52.8 ± 25.3 / /
t/Z 0.353a 2.643b
P 0.729a 0.008b

“/” means no statistical analysis was performed

“a” means difference between W24 and W0, Paired t test was performed

“b” means difference of the rate of increase before and after treatment, Wilcoxon rank sum test was performed